Ionis Pharmaceuticals, headquartered on Gazelle Court in Carlsbad, will present at two healthcare investor conferences in September.

The RNA-focused drugmaker is scheduled to appear at the 21st Annual Wells Fargo Healthcare Conference on Thursday, Sept. 10, and the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, Sept. 16, according to a company press release.

The company did not disclose presentation topics for either event.

Ionis, founded in 1989 and traded on the Nasdaq under the ticker IONS, reported approximately 1,500 employees as of June 30, according to S&P Global Market Intelligence data.

Both presentations will be webcast live through the investor relations section of the Ionis website, with replays posted within 48 hours.